The impact of enzalutamide on quality of life in men with metastatic hormone‐sensitive prostate cancer based on prior therapy, risk, and symptom subgroups
Journal article published in 2022 by
Arnulf Stenzl 
,
Russell Z. Szmulewitz,
Daniel Petrylak,
Jeffrey Holzbeierlein,
Arnauld Villers,
Arun Azad ,
Antonio Alcaraz,
Boris Alekseev,
Taro Iguchi,
Neal D. Shore ,
Francisco Gomez‐Veiga,
Cristina Ivanescu,
Brad Rosbrook,
Krishnan Ramaswamy,
Arijit Ganguli
and other authors.
,
Russell Z. Szmulewitz,
Daniel Petrylak,
Jeffrey Holzbeierlein,
Arnauld Villers,
Arun Azad ,
Antonio Alcaraz,
Boris Alekseev,
Taro Iguchi,
Neal D. Shore ,
Francisco Gomez‐Veiga,
Cristina Ivanescu,
Brad Rosbrook,
Krishnan Ramaswamy,
Arijit Ganguli
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 